NeoImmuneTech, Inc. (KOSDAQ:950220)
1,410.00
-75.00 (-5.05%)
Nov 20, 2026, 3:30 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 139.4 billion as of November 20, 2026. It is the 24,328th most valuable company in the world and the 971st biggest in South Korea. Its market cap has decreased by 49.46% in one year.
Market Cap
139.40B
Enterprise Value
112.86B
Revenue
6.60B
Global Rank
Country Rank
#971 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 139.40B, a decrease of -98.10%. That is a compound annual growth rate of -50.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 139.40B | -65.65% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 200.55B |
| Genomictree | 198.81B |
| GC Genome | 182.58B |
| GC Cell | 148.32B |
| Helixmith | 146.20B |
| Anterogen.Co.,Ltd. | 129.88B |
| MedPacto | 125.28B |
| HLB Therapeutics | 102.77B |